Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will host a conference call on Tuesday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA

Sangamo Therapeutics (SGMO) Continues to Gain, Now Up 50%April 2, 2019 8:39 AM Sangamo Therapeutics (SGMO), Pfizer (PFE) Report Phase 1/2 Interim Data For Investigational Hemophilia A Gene TherapyApril 2, 2019 7:01 AM Sangamo Therapeutics To Host April 2, 2019 Conference Call To Provide Clinical UpdateApril 1, 2019 4:43 PM Sangamo Therapeutics (SGMO) Highlights New Preclinical Data Demonstrating Significant Reduction in Tau Expression with Gene Regulation TechnologyMarch 29, 2019 7:02 AM Sangamo Therapeutics Presents New Preclinical Data Demonstrating Significant Reduction In Tau Expression With Gene Regulation TechnologyMarch 29, 2019 7:00 AM